Delivery Order SPE2DB22D2214-SPE2DB25FS5EU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a $2,999.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Loestrin 21 1-20 tablets (21-count units). The contract, which was not set aside and competitively awarded, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $47,164.04 and a completion date of September 8, 2025. The award was made through open competition with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,291.19 on September 26, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Loestrin 21 1-20 tablets (a contraceptive medication) in quantities of 21 tablets per unit. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was competitively awarded without set-aside restrictions. The contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This competitively awarded, non-set-aside contract carries a ceiling value of $11,276.65 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5EUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's role as a prime vendor under the DLA's pharmaceutical supply chain demonstrates its capability to fulfill federal medical requirements across multiple therapeutic domains. This delivery order for hormonal contraceptive medication represents a routine transaction within the broader scope of pharmaceutical commodities that AmerisourceBergen provides to the Defense Health Agency and other federal healthcare systems through its extensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/30/25 |